Proteomic Profiling of Inflammatory Signaling Molecules in the Tears of Patients on Chronic Glaucoma Medication
Investigative Ophthalmology & Visual Science2011Vol. 52(10), pp. 7385–7385
Citations Over TimeTop 10% of 2011 papers
Tina Wong, Lei Zhou, Jing Li, Louis Tong, Shao Zhao, Xiao Rong Li, Shang Yu, Siew Kwan Koh, Roger W. Beuerman
Abstract
Treatment with topical antiglaucoma medications for longer than 1 year may start to induce ocular surface inflammation. The inflammatory tear protein profile present in chronically medicated glaucomatous eyes appears to be different from that found in primary dry eye. Identification of tear proteins specific to medicated glaucomatous eyes will help to specifically develop targeted screening modalities and therapeutic agents different from current conventional dry eye management.
Related Papers
- → Efficacy of 3 Different Artificial Tears for the Treatment of Dry Eye in Frequent Computer Users and/or Contact Lens Users(2011)32 cited
- → Randomized Controlled Study of Cooled vs Room-Temperature Artificial Tears for Reducing Ocular Surface Irritation After Intravitreal Injection(2023)2 cited
- → Gel Tears(1984)27 cited
- → Serum- and Serum Deprivation-Induced Transcriptional Profiles of Cultured Conjunctival Epithelial Cells(2002)
- [Combining artificial tears---are they always synergistic?].(2003)